Treatment for Patients With Metastatic Thyroid Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

June 30, 2009

Conditions
Thyroid Cancer
Interventions
DRUG

AG 6013736

5 mg po bid

Trial Locations (1)

48109

University of Michigan Cancer Center, Ann Arbor

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Michigan Rogel Cancer Center

OTHER